Skip to main navigation Skip to search Skip to main content

A randomised controlled trial of intravenous dexamethasone combined with interscalene brachial plexus blockade for shoulder surgery

  • M. Desmet*
  • , B. Vanneste
  • , M. Reynvoet
  • , J. Van Cauwelaert
  • , L. Verhelst
  • , H. Pottel
  • , C. Missant
  • , M. Van De Velde
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Summary We recruited patients scheduled for shoulder rotator cuff repair or subacromial decompression under general anaesthesia and interscalene brachial plexus blockade (30 ml ropivacaine 0.5%). We allocated 240 participants into four groups of 60 that were given pre-operative saline 0.9% or dexamethasone 1.25 mg, 2.5 mg or 10 mg, intravenously. We recorded outcomes for 48 h. The median (IQR [range]) time to first postoperative analgesic request after saline was 12.2 (11.0-14.1 [1.8-48]) h, which was extended by intravenous dexamethasone 2.5 mg and 10 mg to 17.4 (14.9-21.5 [7.2-48]) h, p < 0.0001, and 20.1 (17.2-24.3 [1.3-48]) h, p < 0.0001, respectively, but not by dexamethasone 1.25 mg, 14.0 (12.1-17.7 [2.1-48]) h, p = 0.05. Postoperative analgesia was given sooner after rotator cuff repair than subacromial decompression, hazard ratio (95% CI) 2.2 (1.6-3.0), p < 0.0001, but later in older participants, hazard ratio (95% CI) 0.98 (0.97-0.99) per year, p < 0.0001.

Original languageEnglish
Pages (from-to)1180-1185
Number of pages6
JournalAnaesthesia
Volume70
Issue number10
DOIs
Publication statusPublished - 1 Oct 2015

Fingerprint

Dive into the research topics of 'A randomised controlled trial of intravenous dexamethasone combined with interscalene brachial plexus blockade for shoulder surgery'. Together they form a unique fingerprint.

Cite this